Status:
COMPLETED
Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis
Lead Sponsor:
Mardan Medical Complex
Conditions:
Acute Bronchiolitis
Eligibility:
All Genders
3-12 years
Phase:
EARLY_PHASE1
Brief Summary
To compare the efficacy of 3% normal saline nebulization and steroid nebulization in the treatment of bronchiolitis in infants.
Detailed Description
Comparison of 3% normal saline nebulization versus steroid nebulization in the treatment of bronchiolitis Abstract Objectives: To compare the efficacy of 3% normal saline nebulization and steroid nebu...
Eligibility Criteria
Inclusion
- inclusion
- age 3 to 12 months
- both genders
- acute brochiolitis as defined
- exclusion
- prior history of wheezing
- family history of asthma
- pneumonia
- TB
- progressive respiratory distress requiring mechanical ventillation
- underlying diseases (e-g cystic fibrosis, bronchopulmonary dysplasia and cardiac or renal disease)
Exclusion
Key Trial Info
Start Date :
November 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06139029
Start Date
November 15 2022
End Date
March 15 2023
Last Update
November 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faizan Sadiq
Mardan, Kpk, Pakistan